Alaa Atamna
alaaatamna.bsky.social
Alaa Atamna
@alaaatamna.bsky.social
ID physician with focus on transplant and immunocompromised host infectious diseases
Our retrospective study on the impact of early concordant Abx Tx on 30day mortality in 413 hospitalized pts with CRAB bacteremia. 30% received early concordant Tx while 70% received early discordant Tx. The 30-day mortality was 63%.>>

www.mdpi.com/2077-0383/14...
September 15, 2025 at 6:40 PM
The 3rd International CMV Symposium kicks off today!

CMV, the troll of transplantation😈 is not gonna like this.

@kottonnelson.bsky.social
September 12, 2025 at 9:30 AM
Reposted by Alaa Atamna
Invasive Candida infections in solid organ transplant recipients between 2008 and 2020

From the Swiss Transport Cohort Study

High rates of IC, predominately intra-abdominal, with decreasing incidence during the study period. Mortality remains high

www.amjtransplant.org/article/S160... #TxID
August 5, 2025 at 2:06 PM
With both obesity and Clostridioides difficile infections (CDI) increasing globally, we investigated how obesity affects CDI outcomes. Previous studies have shown conflicting results, some link obesity to more severe disease, while others suggest a protective effect, the “obesity survival paradox”.
August 3, 2025 at 2:48 PM
PML is a fatal CNS infection caused by the reactivation of JCV in ICHs. In this review, we discuss risk factors, clinical features, and propose a treatment algorithm based on current data and our experience. Emerging immunotherapies show promise.👇
link.springer.com/article/10.1...
JC Polyomavirus Infection: A Narrative Review - Infectious Diseases and Therapy
Progressive multifocal leukoencephalopathy (PML) is a devastating and often fatal central nervous system infection caused by John Cunningham polyomavirus virus (JCPyV). PML results from JCPyV reactiva...
link.springer.com
July 27, 2025 at 12:19 PM
Reposted by Alaa Atamna
Fungal infections in patients with hematologic malignancies in the pre-triazole era: The dawn of a new era in medical mycology

Umut Akova, Rachel Hicklen, Russell E. Lewis, Thomas J. Walsh, Dimitrios P. Kontoyiannis

@cmijournal.bsky.social

www.clinicalmicrobiologyandinfection.com/article/S119...
June 10, 2025 at 3:53 PM
May 28, 2025 at 1:35 PM
Pts with heme malignancies are at ⬆️ risk for severe COVID19. Vaccines are key preventive strategy, but the response is variable.
This review is based on the authors expert opinions informed by their experiences & literature search

doi.org/10.1080/174740…
May 23, 2025 at 3:11 PM
Malignancy risk is higher among SOT recipients. 4 non-hepatitis viruses recognized as
oncogenic in SOT recipients (EBV,HHV8, HPV, Merkel cell polyomavirus).

This review discusses the prevention of #EBV & #HHV8 in SOT
👇
pmc.ncbi.nlm.nih.gov/articles/PMC...

#TxID
May 19, 2025 at 4:08 AM
Reposted by Alaa Atamna
Hans Hirsch provided a master class in BKV as the keynote for the 5th @fredhutch.bsky.social Symposium on Infections in ICH. Studies have advanced our understanding of pathogens and management - but many questions remain.
May 12, 2025 at 4:24 PM
Reposted by Alaa Atamna
The 2026 CDC yellow book on travel medicine is live at this link for those who are interested @davidofreedman.bsky.social books.google.com/books/about/...
CDC Yellow Book 2026
The CDC Yellow Book has been a trusted resource among healthcare professionals for over half a century. It compiles the US government's current travel health guidance, providing travel medicine specia...
books.google.com
April 23, 2025 at 4:44 PM
Thrilled to join the #ESCMIDglobal 2025 Meet-the-expert session, discussing the impact of ageing metrics on infections and transplant outcomes in older adults. Key topics included immune senescence, infection risks, and vaccine efficacy for solid organ transplant recipients.
April 14, 2025 at 2:24 PM
Reposted by Alaa Atamna
It was an honor to review the data on the link between Ureaplasma spp and Hyperammonemia in Lung Transplant recipients @ESCMID #ESCMIDGlobal 2025. Slides are here for those who want them.

www.dropbox.com/scl/fi/ei4ym...
www.dropbox.com
April 12, 2025 at 8:32 AM
Reposted by Alaa Atamna
Early Rx in Influenza is key!

While pts may not present to the hospital early after sx onset (median 3.6 days after sx onset), early empiric therapy for influenza is recommended by guidelines supported by a growing literature showing benefit but delays in therapy are common.
March 30, 2025 at 4:16 PM